Tallac Therapeutics
PrivateLast Round
Debt
Jul 31, 2023
Total Funding Raised
$67M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Tallac Therapeutics is a biopharmaceutical company that develops antibody-oligonucleotide conjugates to harness innate and adaptive immunity for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tallac Therapeutics Comparables
Compare Tallac Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bolt Biotherapeutics | 81% | |
| ARS Pharmaceuticals | 78% | |
| Canwell Biotech Ltd. | 73% | |
Tallac Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 31, 2023 | ||||
| Series A | Dec 1, 2020 |
Key People
Founding team and executive leadership
Tallac Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series A |
| Lightstone Ventures | Series A |
| Morningside Ventures | Series A |
| MPC | Series A |
| Horizon Technology Finance Corporation | Debt |
| venBio | Series A |
| Morningside Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 38% MoM, reaching 1.9K.
- May 16, 2026
Monthly visitors increased 194% MoM, reaching 2.4K.
Tallac Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tallac Therapeutics's valuation, stock price, and market status.